Abbott India Share Price

ABOUT Abbott India

• Industry Biotechnology & Drugs
• ISIN INE358A01014
• BSE Code 500488
• NSE Code ABBOTINDIA

Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.

MANAGEMENT

• Maithilee Mistry Chief Financial Officer
• Devesh Choudhari Director - Finance
• Jyoti Saraph Director - Finance
• Sangeeta Shetty Chief Compliance Officer, Company Secretary, Associate Director - Secretarial
• Kartik Rajendran Managing Director, Director
• Prithwish Banerji Commercial Director - Womens Health, Metabolics and International Business
• Rajan Kalantre Director - Business Human Resources
• Jejoe Karankumar Director - Medical Affairs
• Anushree Kunhambu Associate Director - New Product Introduction and Therapy Area Strategy
• Anuj Mehra Commercial Director - NeuroLife, GenNext and Vaccines